Navigation Links
Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA
Date:5/28/2013

EAST HANOVER, N.J., May 29, 2013 /PRNewswire/ -- Novartis will present new findings in the treatment of advanced cancers and other diseases with 170 abstracts at two prominent medical meetings. Research across the extensive Novartis product portfolio and pipeline showcases the progress in advancing care for patients with cancer and hematological diseases.

Clinical data from multiple compounds will be featured at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) including Afinitor® (everolimus), Tasigna® (nilotinib) and the pipeline compound LDK3781. The 18th Congress of the European Hematology Association (EHA) will showcase data from JakaviTM (ruxolitinib), Tasigna and Exjade® (deferasirox)2.

"With a pipeline of more than 25 new molecular entities, we are at the forefront of a new era in oncology drug development, working towards advances for cancer patients," said Herve Hoppenot , President, Novartis Oncology . "These data demonstrate our progress in furthering research and development through a highly-targeted approach, matching specific compounds to pathways that are involved in many difficult-to-treat cancers."

Data highlights include:

Studies examining Afinitor in advanced breast cancer at ASCO

  • BOLERO-3 study evaluating potential safety and efficacy of Afinitor in combination with trastuzumab and vinorelbine in women with HER2 positive advanced breast cancer who are resistant to trastuzumab and have been pre-treated with a taxane  (abstract #505; June 2, 9:15 AM)
  • Updates on Afinitor in hormone receptor-positive (HR+) advanced breast cancer, including BOLERO-2 sub-analyses (abstract #553, abstract #557, abstract #558, abstract #561; June 1, 1:15 PM) and a l
    '/>"/>

SOURCE Novartis
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Leaders from Pfizer, Novartis and J&J Challenge Industry to Disrupt R&D
2. Novartis launches the Cancer Cell Line Encyclopedia to catalog worlds cancer cell lines
3. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
4. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
5. SPIE Defense, Security, and Sensing 2013 Highlights Vital Role of Photonics for Defense and Commercial Applications
6. InterMune Reports First Quarter 2013 Financial Results and Business Highlights
7. Aurigene Highlights its PD-1 peptide, Bet Bromodomain and NAMPT Inhibitors Program at AACR 2013
8. Pittcon 2013 Announces Exposition Highlights
9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
10. Soligenix Reports Year-End 2012 Financial Results and Highlights Recent Accomplishments
11. InterMune Reports Fourth Quarter And Full Year 2012 Financial Results And Business Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 AcelRx ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... results after market close on Monday, March 9th, ... call at 4:30 p.m. Eastern Time (1:30 p.m. ...
(Date:3/4/2015)... 2015 Vegalab announced the acquisition of Ecowin, ... year. As part of the acquisition, Ecowin rebranded itself ... his role as CEO for the company,s Korea operations. ... work alongside Koo and oversee developments at the new ... Koo founded Ecowin in 2008 to ...
(Date:3/4/2015)... Launched by the Assistance Publique - ... 2011, ,SARAH, - the French national collaborative randomized ... advanced hepatocellular carcinoma (HCC) has enrolled more than 400 ... a large French study of patients with advanced, inoperable ... patient enrolment, exceeding its 400-patient target, according to its ...
(Date:3/4/2015)... 2015   ... und Therapie, Strahlendosismanagement und IT-Lösungen für die gesamte ... Philips (NYSE: PHG, AEX: PHIA) gab heute ... (ECR) bekannt, der vom 4. bis 8. März in ... Ständen Nr. 102 and 110 wird das ...
Breaking Biology Technology:AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6
... Pharmaceuticals,Inc. (Nasdaq: AMLN ) today announced that ... diabetes drugs, BYETTA(R) (exenatide) injection and,SYMLIN(R) (pramlintide acetate) ... at the American Diabetes Association,s 68th Annual,Scientific Sessions ... June 6 to,10. The company will also host ...
... CHICAGO, June 2 Alternative Reproductive Resources,(ARR), a ... donors and surrogate mothers, has announced a program ... egg donor selection process., Called Extended Choice, ... "first choice" on selected egg donors during a ...
... The Scarborough Hospital (TSH),Canada,s largest urban community ... and communications between physicians. The,implementation of Chyma(TM) for ... with the busy ER departments at the two ... department of general medicine., "Chyma(TM) reflects the ...
Cached Biology Technology:Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 2Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 4Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 5Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 6Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 7ARR Offers Parents 'Extended Choice' in Egg Donor Selections 2Canada's Largest Urban Community Hospital Chooses Chyma(TM) On-Call Physician Scheduling Technology 2
(Date:2/5/2015)... New Market Research Reports Title ... To 2020 has Been Added to GrandViewReseach.com Report Database ... to reach USD 5.10 billion by 2020, according to ... cameras help identify the site of tissue damage in ... demand in medical imaging applications. They have been extensively ...
(Date:2/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6lngtl/global_biometrics ... "Global Biometrics Market (2014-2020): Market Forecast By Technologies, ... to their offering. , In ... is anticipated to overtake North America ... spending towards IT security, government biometric based projects ...
(Date:2/5/2015)... 3, 2015 Despite a lack of ... such as consumer electronics, automotive, storage and telecommunication ... technology (SMT) screen printers. Innovations in electronics and ... push the adoption curve up. Meanwhile, sale volumes ... glue dispensers are indispensable in the production of ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
... for the Investigation of Health Hazards of Chemical Compounds ... the annual list of MAK and BAT Values to ... the beginning of July. These constitute the set of ... careful scientific examination. 60 changes and additions to the ...
... is available in Spanish . The journal ... 1st of August the results of a detailed research work ... 50 million years. The study has been carried out with ... Malaysia and Panama., The results obtained prove that the main ...
... next-generation identity management platform, complete with biometric ... formatting, and background ... Microsystems, Inc.,and Aware, Inc. (Nasdaq: AWRE ), a ... Aware,s Biometric Services Platform,(BioSP(TM)) with Sun identity management solutions. ...
Cached Biology News:New and revised limits ensure safety in the workplace 2New and revised limits ensure safety in the workplace 3Fossil and molecular evidence reveals the history of major marine biodiversity hotspots 2Sun Microsystems and Aware, Inc. Announce Integration of Aware's BioSP with Sun Identity Management Solutions 2Sun Microsystems and Aware, Inc. Announce Integration of Aware's BioSP with Sun Identity Management Solutions 3Sun Microsystems and Aware, Inc. Announce Integration of Aware's BioSP with Sun Identity Management Solutions 4Sun Microsystems and Aware, Inc. Announce Integration of Aware's BioSP with Sun Identity Management Solutions 5
...
... analytical solutions is the 6890N network gas ... you to share business and scientific data ... Just as its 6890 GC predecessors, this ... needed for research and method development in ...
... infusion kits reduce the time and expense ... providing sterile equipment to reduce the risk ... need for one animal, including swivel, tubing, ... be cut to the exact lengths you ...
... The PolarScreen Peroxisome Proliferator-Activated Receptor-gamma ... a sensitive and efficient method ... PPARGamma ligands using fluorescence polarization ... PPARGamma-Ligand binding domain (PPARGamma-LBD) with ...
Biology Products: